X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (13) 13
oncology (13) 13
humans (12) 12
aged (11) 11
female (11) 11
middle aged (10) 10
aged, 80 and over (8) 8
adult (7) 7
hematology, oncology and palliative medicine (7) 7
male (7) 7
netherlands (6) 6
retrospective studies (6) 6
treatment outcome (6) 6
chemotherapy (5) 5
risk factors (5) 5
tumors (5) 5
young adult (5) 5
cancer (4) 4
care and treatment (4) 4
imatinib (4) 4
prognosis (4) 4
sarcoma (4) 4
survival (4) 4
analysis (3) 3
antineoplastic agents - therapeutic use (3) 3
cancer patients (3) 3
carcinoma (3) 3
chemotherapy, adjuvant (3) 3
disease-free survival (3) 3
kaplan-meier estimate (3) 3
metastasis (3) 3
neoplasm staging (3) 3
patient outcomes (3) 3
radiology, nuclear medicine & medical imaging (3) 3
registries (3) 3
age factors (2) 2
anthracyclines (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
disease progression (2) 2
drug administration schedule (2) 2
drug dosages (2) 2
elderly (2) 2
endometrial cancer (2) 2
follow-up studies (2) 2
fraction radiotherapy (2) 2
gastrointestinal stromal tumor (2) 2
gastrointestinal stromal tumors - drug therapy (2) 2
gastrointestinal stromal tumors - mortality (2) 2
gastrointestinal stromal tumors - pathology (2) 2
gist (2) 2
health aspects (2) 2
incidence (2) 2
liposarcoma (2) 2
multivariate analysis (2) 2
mutation (2) 2
neoplasm metastasis (2) 2
ovarian cancer (2) 2
ovarian neoplasms - drug therapy (2) 2
ovarian neoplasms - pathology (2) 2
palliative care (2) 2
palliative care - methods (2) 2
patients (2) 2
pharmacology & pharmacy (2) 2
practice patterns, physicians (2) 2
quality of life (2) 2
radiotherapy (2) 2
risk (2) 2
single (2) 2
soft tissue sarcoma (2) 2
surveys and questionnaires (2) 2
time factors (2) 2
toxicity (2) 2
trabectedin (2) 2
abridged index medicus (1) 1
adolescent (1) 1
adverse events (1) 1
age (1) 1
aged patients (1) 1
analgesics (1) 1
analysis of variance (1) 1
angina pectoris - epidemiology (1) 1
anthracycline (1) 1
antibiotics, antineoplastic - administration & dosage (1) 1
antineoplastic agents, alkylating - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
association (1) 1
barriers (1) 1
benzamides (1) 1
bevacizumab (1) 1
biomarker (1) 1
biomarkers, tumor - analysis (1) 1
blood-pressure (1) 1
bone metastases (1) 1
bone neoplasms (1) 1
bone neoplasms - psychology (1) 1
bone neoplasms - radiotherapy (1) 1
bone neoplasms - secondary (1) 1
cancer pain (1) 1
cancer pain - therapy (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
European Journal of Cancer, ISSN 0959-8049, 11/2017, Volume 86, pp. 318 - 325
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2017, Volume 76, pp. 76 - 83
Journal Article
Journal of Geriatric Oncology, ISSN 1879-4068, 11/2019, Volume 10, Issue 6, pp. S102 - S102
Journal Article
Journal of Geriatric Oncology, ISSN 1879-4068, 11/2019, Volume 10, Issue 6, p. S102
Journal Article
Therapeutic Drug Monitoring, ISSN 0163-4356, 2019, Volume 41, Issue 5, pp. 561 - 567
BACKGROUND: Oral anticancer drugs show a high interpatient variability in pharmacokinetics (PK), leading to large differences in drug exposure. For many of... 
EXPOSURE-RESPONSE ANALYSIS | individualized dosing | HUMAN PLASMA | PAZOPANIB | personalized dosing | TAMOXIFEN | QUANTIFICATION | KINASE INHIBITORS | RENAL-CELL CARCINOMA | DOSE-ESCALATION | oral anticancer drugs | IMATINIB | PHARMACOLOGY & PHARMACY | TOXICOLOGY | MEDICAL LABORATORY TECHNOLOGY | TDM | PHASE-I | Index Medicus
Journal Article
Oncotarget, ISSN 1949-2553, 2015, Volume 6, Issue 31, pp. 32228 - 32243
PURPOSE: Preclinical tumor models show that chemotherapy has immune modulatory properties which can be exploited in the context of immunotherapy. The purpose... 
Tumor immunity | Immunotherapy | Chemoresistance | Ovarian cancer | P53 | LONG PEPTIDE VACCINE | NUDE-MICE | DENDRITIC CELLS | SOLID TUMORS | ovarian cancer | tumor immunity | p53 | CELL BIOLOGY | chemoresistance | INTERFERON-ALPHA | I INTERFERONS | COLORECTAL-CANCER | immunotherapy | CD8(+) T-LYMPHOCYTES | SUPPRESSOR-CELLS | CARCINOMA
Journal Article
Journal Article
European Journal of Cancer, ISSN 0959-8049, 10/2017, Volume 84, p. 370
The authors regret that reference 5 (Milam et al., 2011) in the original article was included in the reference list incorrectly, and it should not have been... 
Oncology | Cancer Research
Journal Article
Sarcoma, ISSN 1357-714X, 2019, Volume 2019, pp. 3234205 - 11
Trabectedin and ifosfamide are among the few cytostatic agents active in advanced soft tissue sarcomas (STSs). Trabectedin is most potent against so-called... 
Crizotinib | Anthracyclines | Sarcoma | Ifosfamide | Economic aspects | Comparative analysis | Medical care, Cost of
Journal Article
Clinical Sarcoma Research, ISSN 2045-3329, 2017, Volume 7, Issue 1, p. 2
BACKGROUND: Trabectedin has shown efficacy against soft tissue sarcomas (STS) and has manageable toxicity. Trabectedin is administered through central venous... 
SYSTEM | Adverse events | CATHETERS | ONCOLOGY | Soft tissue sarcoma | Central venous catheters | COMPLICATIONS | Trabectedin | RETROSPECTIVE ANALYSIS | TUMORS
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 2012, Volume 18, Issue 20, pp. 5780 - 5787
PURPOSE: Imatinib minimal (trough) plasma concentrations after one month of treatment have shown a significant association with clinical benefit in patients... 
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 78, Issue 5, pp. 1337 - 1344
Journal Article